Nima Zaal, PT, DPT | |
540 Main St, Belleville, MI 48111-2650 | |
(734) 489-6440 | |
(734) 418-7553 |
Full Name | Nima Zaal |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 4 Years |
Location | 540 Main St, Belleville, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669055398 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ivyrehab Michigan Llc | 6901165893 | 95 |
News Archive
QR Pharma, Inc., a clinical stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative disorders, announced today that Dr. Maria Maccecchini, CEO, will be presenting new data on its lead compound "Posiphen® Recovers Memory, Learning and Brain Function in Alzheimer Transgenic Mice" at the 12th Annual Biotech Symposium, taking place October 22, 2012 in Philadelphia, PA.
A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States.
An international research team led by the Research Institute of the McGill University Health Centre and Lund University has provided new evidence that aortic valve disease may be preventable.
The number of people who voluntarily took HIV tests in Singapore in 2007 did not improve despite increased access of rapid HIV testing kits to more than 60 clinics, Singapore's Today reports.
› Verified 1 days ago
Entity Name | Ivyrehab Michigan Llc |
---|---|
Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Entity Identifiers | NPI Number: 1104337120 PECOS PAC ID: 6901165893 Enrollment ID: O20180123001245 |
News Archive
QR Pharma, Inc., a clinical stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative disorders, announced today that Dr. Maria Maccecchini, CEO, will be presenting new data on its lead compound "Posiphen® Recovers Memory, Learning and Brain Function in Alzheimer Transgenic Mice" at the 12th Annual Biotech Symposium, taking place October 22, 2012 in Philadelphia, PA.
A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States.
An international research team led by the Research Institute of the McGill University Health Centre and Lund University has provided new evidence that aortic valve disease may be preventable.
The number of people who voluntarily took HIV tests in Singapore in 2007 did not improve despite increased access of rapid HIV testing kits to more than 60 clinics, Singapore's Today reports.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Nima Zaal, PT, DPT 1311 Mamaroneck Ave Ste 140, White Plains, NY 10605-5224 Ph: (888) 830-4125 | Nima Zaal, PT, DPT 540 Main St, Belleville, MI 48111-2650 Ph: (734) 489-6440 |
News Archive
QR Pharma, Inc., a clinical stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative disorders, announced today that Dr. Maria Maccecchini, CEO, will be presenting new data on its lead compound "Posiphen® Recovers Memory, Learning and Brain Function in Alzheimer Transgenic Mice" at the 12th Annual Biotech Symposium, taking place October 22, 2012 in Philadelphia, PA.
A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States.
An international research team led by the Research Institute of the McGill University Health Centre and Lund University has provided new evidence that aortic valve disease may be preventable.
The number of people who voluntarily took HIV tests in Singapore in 2007 did not improve despite increased access of rapid HIV testing kits to more than 60 clinics, Singapore's Today reports.
› Verified 1 days ago